Healthcare
Koninklijke Philips N.V.(RYLPF)
Live Price
Offline$25.81
+0.00% today
1Y Change
+11.17%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $21.62B
- Revenue Growth
- -1.1%
- EPS Growth
- +225.3%
- Dividend Yield
- 3.7%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Koninklijke Philips N.V. (RYLPF) is a Healthcare stock with a market cap of $21.62B and listed on OTC. The stock last traded around $25.81 and up 11.2% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -1.1%, EPS growth of +225.3%, a dividend yield of 3.7%. What stands out right now is revenue -1.1%, EPS +225.3%, free cash flow +1.1% with operating margin 8.6% and ROIC 5.7%. The dividend matters to the case here, with a current yield around 3.7%. Valuation is more restrained than many high-expectation growth names at P/E 24.2 and price/sales 1.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RYLPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-1.1% vs +7.6% peer median
Operating Margin
Below sector median
+8.6% vs +19.4% peer median
P/E
Below sector median
24.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -1.1% and EPS is at +225.3%, with operating margin around 8.6%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.8% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +2.3% | +2.3% | -0.9% |
2026 Feb 10, 2026 | +25.0% | +0.0% | +0.0% | -10.0% |
2025 Nov 4, 2025 | -38.8% | +0.0% | +0.0% | -2.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RYLPF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RYLPF Max Drawdown
-22.90%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RYLPF and SPY.
Company Overview
Koninklijke Philips N.V.
Other OTC
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Leadership
- Roy W. O. Jakobs
- IPO Date
- Nov 30, 2015
- Employees
- 67.2k
- Street Address
- Philips Center
- Mailing
- Amsterdam, 1096 BC
- Region
- Amsterdam, NL
- Reporting Currency
- USD
- Investor Line
- 31 20 597 7777
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 24.2
- EV/EBITDA
- 9.9
- Price/Sales
- 1.2
- Price/Book
- 2.0
Growth
- Revenue
- -1.1%
- EPS
- +225.3%
- Free Cash Flow
- +1.1%
Profitability
- Gross Margin
- 45.2%
- Operating Margin
- 8.6%
- Net Margin
- 5.0%
- ROE
- 8.2%
- ROIC
- 5.7%
Balance Sheet
- Debt/Equity
- 0.74
- Current Ratio
- 1.32
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.